Actively Recruiting

Age: 6Months - 24Months
All Genders
NCT06093152

Video Assisted Study of Salbutamol Response in Viral Wheezing

Led by University of Oulu · Updated on 2025-02-13

50

Participants Needed

1

Research Sites

162 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study is video assisted cross-over study evaluating the effect of inhaled salbutamol in wheeze in children 6-24 months old.

CONDITIONS

Official Title

Video Assisted Study of Salbutamol Response in Viral Wheezing

Who Can Participate

Age: 6Months - 24Months
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Wheezing
  • Salbutamol-treatment in emergency department prescribed
Not Eligible

You will not qualify if you...

  • Need for immediate resuscitation
  • Immediate transfer to ICU
  • Suspicion of pneumonia based on the auscultation finding
  • Suspicion of airway foreign body

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Department of Pediatrics, Oulu University Hospital

Oulu, Finland, 90130

Actively Recruiting

Loading map...

Research Team

V

Ville Lindholm, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here